Extracellular matrix-like surfactant polymers containing arginine-glycine-aspartic acid (RGD) peptides. 2004

Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
Department of Macromolecular Science, Wickenden 201, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-7207, USA.

We report on a novel series of biomimetic polymers exhibiting interfacial properties similar to the extracellular matrix. A series of well-defined surfactant polymers were synthesized by simultaneously incorporating arginine-glycine-aspartic acid (RGD) peptide, dextran oligosaccharide, and hexyl ligands with controlled feed ratios onto a poly(vinyl amine) (PVAm) backbone. The peptide sequence was H-GSSSGRGDSPA-NH(2) (Pep) having a hydrophilic extender at the amino terminus and capped carboxy terminus. The peptide-to-dextran (Pep:Dex) ratios were varied to create surfactants having 0, 25, 50, 75, and 100 mol-% peptide relative to dextran. The surfactants were characterized by IR, NMR and atomic force microscopy (AFM) for composition and surface active properties. AFM confirmed full surface coverage of PVAm(Pep)(100%) on graphite, and supported the mechanism of interdigitation of hexyl ligands between surfactant molecules within a specified range of hexyl chain densities. the attachment and growth of human pulmonary artery endothelial cells on the PVAm(Pep)(100%) surface was identical to the fibronectin positive control. Cell adhesion decreased dramatically with decreasing peptide density on the surfactant polymers. Molecular model of a peptide surfactant polymer, consisting of poly(vinyl amine) backbone with peptide, dextran oligosaccharide and hexyl branches coupled to the polymer chain.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property

Related Publications

Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
November 1997, Gene therapy,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
February 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
January 1995, Diabetes care,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
January 2007, Molecular reproduction and development,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
April 2005, The Journal of physiology,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
September 2020, ACS nano,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
January 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
January 1987, Methods in enzymology,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
January 1998, Clinical and experimental pharmacology & physiology,
Eric H Anderson, and Mark A Ruegsegger, and Gurunathan Murugesan, and Kandice Kottke-Marchant, and Roger E Marchant
February 1994, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!